119 related articles for article (PubMed ID: 36974812)
1. The Regulatory Role of Nuclear Respiratory Factor 1 in Bladder Cancer Cells.
Lee YH; Wu RC; Mai HC; Huang WL; Wu CH; Yang YL; Hsieh PF; Lin VC
Anticancer Res; 2023 Apr; 43(4):1521-1531. PubMed ID: 36974812
[TBL] [Abstract][Full Text] [Related]
2. Verbascoside inhibits the epithelial-mesenchymal transition of prostate cancer cells through high-mobility group box 1/receptor for advanced glycation end-products/TGF-β pathway.
Wu CH; Chen CH; Hsieh PF; Lee YH; Kuo WW; Wu RC; Hung CH; Yang YL; Lin VC
Environ Toxicol; 2021 Jun; 36(6):1080-1089. PubMed ID: 33522686
[TBL] [Abstract][Full Text] [Related]
3. HMGB1 attenuates TGF-β-induced epithelial-mesenchymal transition of FaDu hypopharyngeal carcinoma cells through regulation of RAGE expression.
Li Y; Wang P; Zhao J; Li H; Liu D; Zhu W
Mol Cell Biochem; 2017 Jul; 431(1-2):1-10. PubMed ID: 28285361
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Respiratory Factor 1 Overexpression Inhibits Proliferation and Migration of PC3 Prostate Cancer Cells.
Wu CH; Hsieh PF; Lee YH; Kuo WW; Wu RC; Lin YY; Hung CH; Hsieh ML; Pang ST; Yang YL; Lin VC
Cancer Genomics Proteomics; 2022; 19(5):614-623. PubMed ID: 35985685
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
[TBL] [Abstract][Full Text] [Related]
6. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
Wu CL; Ho JY; Chou SC; Yu DS
Oncotarget; 2016 May; 7(18):26593-603. PubMed ID: 27058893
[TBL] [Abstract][Full Text] [Related]
7. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA
Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366
[TBL] [Abstract][Full Text] [Related]
9. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of transforming growth factor-β1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cells.
Li W; Kidiyoor A; Hu Y; Guo C; Liu M; Yao X; Zhang Y; Peng B; Zheng J
Tumour Biol; 2015 Feb; 36(2):1155-62. PubMed ID: 25722217
[TBL] [Abstract][Full Text] [Related]
11. HMGB1 Enhances the AGE-Induced Expression of CTGF and TGF-β via RAGE-Dependent Signaling in Renal Tubular Epithelial Cells.
Cheng M; Liu H; Zhang D; Liu Y; Wang C; Liu F; Chen J
Am J Nephrol; 2015; 41(3):257-66. PubMed ID: 25924590
[TBL] [Abstract][Full Text] [Related]
12. High-mobility group box 1: a novel inducer of the epithelial-mesenchymal transition in colorectal carcinoma.
Zhu L; Li X; Chen Y; Fang J; Ge Z
Cancer Lett; 2015 Feb; 357(2):527-34. PubMed ID: 25511739
[TBL] [Abstract][Full Text] [Related]
13. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration in vitro.
Pang X; Zhang Y; Zhang S
Oncol Rep; 2017 Feb; 37(2):831-840. PubMed ID: 28000879
[TBL] [Abstract][Full Text] [Related]
15. HMGB1 release by urothelial carcinoma cells in response to Bacillus Calmette-Guérin functions as a paracrine factor to potentiate the direct cellular effects of Bacillus Calmette-Guérin.
Zhang G; Chen F; Cao Y; Amos JV; Shah G; See WA
J Urol; 2013 Sep; 190(3):1076-82. PubMed ID: 23353043
[TBL] [Abstract][Full Text] [Related]
16. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
17. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
[TBL] [Abstract][Full Text] [Related]
18. High-mobility group box-B1 (HMGB1) mediates the hypoxia-induced mesenchymal transition of osteoblast cells via activating ERK/JNK signaling.
Qiu Y; Chen Y; Zeng T; Guo W; Zhou W; Yang X
Cell Biol Int; 2016 Nov; 40(11):1152-1161. PubMed ID: 27106169
[TBL] [Abstract][Full Text] [Related]
19. Highly Expressed LINC00958 Modulates the Growth and Epithelial-Mesenchymal Transition of Bladder Cancer Cells Through
Xiao Y; He L; Dong Y; Huang Y; Ma L; Li W
Cancer Biother Radiopharm; 2023 Aug; 38(6):405-414. PubMed ID: 35766943
[No Abstract] [Full Text] [Related]
20. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
